Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Abedalrahman Almashayekh's research focuses on understanding complex medical conditions and their treatment. Recent publications investigate post-transplant lymphoproliferative disorder, particularly in cases where initial diagnostic biopsies were negative. Almashayekh also studies acute kidney injury (AKI) in patients receiving chimeric antigen receptor T cells, identifying risk factors and patient characteristics. Another area of investigation is the role of hypophosphatemia as a marker for immune effector cell-associated neurotoxicity syndrome in these same recipients. Additionally, Almashayekh has explored the use of SGLT2 inhibitors for refractory hypomagnesemia in both diabetic and non-diabetic patients, presenting findings from a multicenter case series. Almashayekh has collaborated with researchers at the University of Arkansas for Medical Sciences, including Rahaf Omaish, Nithin Karakala, Lean Alkhatib, and Nishank Jain.
Metrics
- h-index: 1
- Publications: 5
- Citations: 1
Selected Publications
-
Acute Kidney Injury in Recipients of Chimeric Antigen Receptor T-Cell Therapy: Clinical Characteristics and Impact on Mortality (2026)
-
AKI in Patients Receiving Chimeric Antigen Receptor T Cells: Risk Factors and Characteristics (2025)
-
Hypophosphatemia as a Marker for Immune Effector Cell-Associated Neurotoxicity Syndrome in Chimeric Antigen Receptor T Cell Recipients (2025)
-
Post-Transplant Lymphoproliferative Disorder: A Diagnostic Challenge Following Negative Needle Biopsy (2025)
-
SGLT2 Inhibitors as a Therapeutic Option for Both Acute and Chronic Refractory Hypomagnesemia in Diabetic and Nondiabetic Patients: A Multicenter Case Series (2025)
Collaboration Network
Top Collaborators
- Post-Transplant Lymphoproliferative Disorder: A Diagnostic Challenge Following Negative Needle Biopsy
- Hypophosphatemia as a Marker for Immune Effector Cell-Associated Neurotoxicity Syndrome in Chimeric Antigen Receptor T Cell Recipients
- AKI in Patients Receiving Chimeric Antigen Receptor T Cells: Risk Factors and Characteristics
- SGLT2 Inhibitors as a Therapeutic Option for Both Acute and Chronic Refractory Hypomagnesemia in Diabetic and Nondiabetic Patients: A Multicenter Case Series
- Hypophosphatemia as a Marker for Immune Effector Cell-Associated Neurotoxicity Syndrome in Chimeric Antigen Receptor T Cell Recipients
- Post-Transplant Lymphoproliferative Disorder: A Diagnostic Challenge Following Negative Needle Biopsy
- AKI in Patients Receiving Chimeric Antigen Receptor T Cells: Risk Factors and Characteristics
- Hypophosphatemia as a Marker for Immune Effector Cell-Associated Neurotoxicity Syndrome in Chimeric Antigen Receptor T Cell Recipients
- AKI in Patients Receiving Chimeric Antigen Receptor T Cells: Risk Factors and Characteristics
- SGLT2 Inhibitors as a Therapeutic Option for Both Acute and Chronic Refractory Hypomagnesemia in Diabetic and Nondiabetic Patients: A Multicenter Case Series
- SGLT2 Inhibitors as a Therapeutic Option for Both Acute and Chronic Refractory Hypomagnesemia in Diabetic and Nondiabetic Patients: A Multicenter Case Series
- SGLT2 Inhibitors as a Therapeutic Option for Both Acute and Chronic Refractory Hypomagnesemia in Diabetic and Nondiabetic Patients: A Multicenter Case Series
- SGLT2 Inhibitors as a Therapeutic Option for Both Acute and Chronic Refractory Hypomagnesemia in Diabetic and Nondiabetic Patients: A Multicenter Case Series
- SGLT2 Inhibitors as a Therapeutic Option for Both Acute and Chronic Refractory Hypomagnesemia in Diabetic and Nondiabetic Patients: A Multicenter Case Series
- SGLT2 Inhibitors as a Therapeutic Option for Both Acute and Chronic Refractory Hypomagnesemia in Diabetic and Nondiabetic Patients: A Multicenter Case Series
- Post-Transplant Lymphoproliferative Disorder: A Diagnostic Challenge Following Negative Needle Biopsy
- Post-Transplant Lymphoproliferative Disorder: A Diagnostic Challenge Following Negative Needle Biopsy
- AKI in Patients Receiving Chimeric Antigen Receptor T Cells: Risk Factors and Characteristics
- AKI in Patients Receiving Chimeric Antigen Receptor T Cells: Risk Factors and Characteristics
- AKI in Patients Receiving Chimeric Antigen Receptor T Cells: Risk Factors and Characteristics
Similar Researchers
Based on overlapping research topics